Rbc Life Sciences Stock Net Income

RBCL Stock  USD 0.0004  0.00  0.00%   
Fundamental analysis of RBC Life allows traders to better anticipate movements in RBC Life's stock price by examining its financial health and performance throughout various phases of its business cycle.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

RBC Life Sciences Company Net Income Analysis

RBC Life's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current RBC Life Net Income

    
  (756.28 K)  
Most of RBC Life's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RBC Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, RBC Life Sciences reported net income of (756,284). This is 100.07% lower than that of the Personal Products sector and 100.08% lower than that of the Consumer Staples industry. The net income for all United States stocks is 100.13% higher than that of the company.

RBC Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RBC Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RBC Life could also be used in its relative valuation, which is a method of valuing RBC Life by comparing valuation metrics of similar companies.
RBC Life is currently under evaluation in net income category among its peers.

RBC Fundamentals

About RBC Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze RBC Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RBC Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RBC Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

Other Information on Investing in RBC Pink Sheet

RBC Life financial ratios help investors to determine whether RBC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Life security.